PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

Nephrology

Kidney disease drugs, outcomes evidence, payer coverage, dialysis-adjacent access, and affordability.

1 article·Lives underPricing & Access Evidence·Last updated 2026-07-01

Evidence· July 1, 2026 · 17 min read

ACE Inhibitors and ARBs in FAERS: 46,000 Reports in 2025 and the Core Signals

By Ran Chen#Hypertension #Cardiovascular #Real-World Evidence